References
-
1
Ilyin S E, Belkowski S M, Plata-Salaman C R.
Biomarker discovery and validation: technologies and integrative approaches.
Trends Biotechnol.
2004;
22 (8)
411-416
-
2
Pritzker K P, Azad A.
Genomic biomarkers for cancer assessment: implementation challenges for laboratory practice.
Clin Biochem.
2004;
37 (7)
642-646
-
3
Brugge W R.
Approach to cystic pancreatic lesions.
Gastrointest Endosc Clin N Am.
2005;
15 (3)
485-496, viii
-
4
Khalid A. et al .
Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
Gut.
2004;
53 (12)
1860-1865
-
5
McCarthy D M. et al .
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases.
Appl Immunohistochem Mol Morphol.
2003;
11 (3)
238-243
-
6
Frossard J L. et al .
Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions.
Am J Gastroenterol.
2003;
98 (7)
1516-1524
-
7
Hammel P. et al .
Diagnostic value of CA 72 - 4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions.
Eur J Gastroenterol Hepatol.
1998;
10 (4)
345-348
-
8
Brugge W R. et al .
Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.
Gastroenterology.
2004;
126 (4)
1330-1336
-
9
Goggins M.
Molecular markers of early pancreatic cancer.
J Clin Oncol.
2005;
23 (20)
4524-4531
-
10
Matsubayashi H. et al .
DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Cancer Res.
2006;
66 (2)
1208-1217
-
11
Wilentz R E. et al .
K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Cancer.
1998;
82 (1)
96-103
-
12
Yamada T. et al .
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Clin Cancer Res.
1998;
4 (6)
1527-1532
-
13
Ohuchida K. et al .
A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Cancer.
2004;
101 (10)
2309-2317
-
14
Myung S J. et al .
Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
Gastrointest Endosc.
2000;
51 (6)
708-713
-
15
Brunner T B. et al .
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
Cancer Res.
2005;
65 (18)
8433-8441
-
16
Caldas C. et al .
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.
Nat Genet.
1994;
8 (1)
27-32
-
17
Kalthoff H. et al .
p53 and K-RAS alterations in pancreatic epithelial cell lesions.
Oncogene.
1993;
8 (2)
289-298
-
18
Tada M. et al .
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
Cancer Res.
1993;
53 (11)
2472-2474
-
19
Mulcahy H E. et al .
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
Clin Cancer Res.
1998;
4 (2)
271-275
-
20
Shi C. et al .
LigAmp for sensitive detection of single-nucleotide differences.
Nat Methods.
2004;
1 (2)
141-147
-
21
Caldas C. et al .
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Cancer Res.
1994;
54 (13)
3568-3573
-
22
Hollstein M. et al .
p53 mutations in human cancers.
Science.
1991;
253 (5015)
49-53
-
23
Sturm P D. et al .
The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region.
J Pathol.
1998;
186 (3)
247-253
-
24
Itoi T. et al .
Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses.
Oncol Rep.
2005;
13 (2)
229-234
-
25
Franquemont D W.
Differentiation and risk assessment of gastrointestinal stromal tumors.
Am J Clin Pathol.
1995;
103 (1)
41-47
-
26
Rosch T. et al .
Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors.
Scand J Gastroenterol.
1992;
27 (1)
1-8
-
27
Miettinen M, Virolainen M, Maarit Sarlomo R.
Gastrointestinal stromal tumors-value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas.
Am J Surg Pathol.
1995;
19 (2)
207-216
-
28
Kindblom L G. et al .
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.
Am J Pathol.
1998;
152 (5)
1259-1269
-
29
Boyce G A. et al .
Evaluation of submucosal upper gastrointestinal tract lesions by endoscopic ultrasound.
Gastrointest Endosc.
1991;
37 (4)
449-454
-
30
DeMatteo R P. et al .
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.
Ann Surg.
2000;
231 (1)
51-58
-
31
Wiersema M J. et al .
Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment.
Gastroenterology.
1997;
112 (4)
1087-1095
-
32
Matsui M. et al .
Preliminary results of fine needle aspiration biopsy histology in upper gastrointestinal submucosal tumors.
Endoscopy.
1998;
30 (9)
750-755
-
33
Amin M B. et al .
Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
Am J Clin Pathol.
1993;
100 (4)
428-432
-
34
Carrillo R. et al .
Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors.
Hum Pathol.
1997;
28 (2)
160-165
-
35
Sarlomo-Rikala M. et al .
CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Mod Pathol.
1998;
11 (8)
728-734
-
36
Graadt van Roggen J F, van Velthuysen M L, Hogendoorn P C.
The histopathological differential diagnosis of gastrointestinal stromal tumours.
J Clin Pathol.
2001;
54 (2)
96-102
-
37
Ueyama T. et al .
A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors.
Cancer.
1992;
69 (4)
947-955
-
38
Seidal T, Edvardsson H.
Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours.
Histopathology.
1999;
34 (5)
416-424
-
39
Newman P L, Wadden C, Fletcher C D.
Gastrointestinal stromal tumours: correlation of immunophenotype with clinicopathological features.
J Pathol.
1991;
164
107 (2)-117
-
40
Ando N. et al .
The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis.
Gastrointest Endosc.
2002 ;
55 (1)
37-43
Michael B. Wallace, M.D.
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Mayo Clinic Jacksonville
4500 San Pablo Rd
Jacksonville, FL 32224
eMail: wallace.michael@mayo.edu
